Product Information
DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.3048 per EA under NDC 42858072701. Its NADAC has been published 230 times since Feb 2, 2022.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAMIN 30 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858072701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213111On Market Since
9/9/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 230 times since Feb 2, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3048 per EA |
|---|---|
| All-time high | $0.3587 (Aug 16, 2023) |
| All-time low | $0.2416 (Jul 17, 2024) |
| 52-week high | $0.3373 |
| 52-week low | $0.3037 |
| Median price | $0.3124 |
| Average price | $0.3120 |
| Largest weekly change | -26.9% (Nov 20, 2024) |
| Weeks tracked | 230 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Rhodes Pharmaceuticals L.P., is $0.3048 per EA (NDC 42858072701), effective Jun 24, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has held within roughly two percent of its current level. It has been tracked across 230 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?
Since Feb 2, 2022, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.3587 (Aug 16, 2023), with a median of $0.3124 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHETAMIN 30 MG TAB, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?
DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 42858072701) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification